JP Morgan Chase
GNPX icon

JP Morgan Chase’s Genprex GNPX Stock Holding History

JP Morgan Chase’s Portfolio GNPX Stock Details GNPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Hold
0
– – – 7692
2026
Q1 		– Hold
0
– – – 7462
2025
Q4 		– Hold
0
– – – 7361
2025
Q3 		– Hold
0
– – – 7353
2025
Q2 		– Hold
0
– – – 7019
2025
Q1 		– Hold
0
– – – 7265
2024
Q4 		– Hold
0
– – – 7339
2024
Q3 		– Hold
0
– – – 7353
2024
Q2 		– Hold
0
– – – 7217
2024
Q1 		– Hold
0
– – – 7199
2023
Q4 		– Hold
0
– – – 7174
2023
Q3 		– Hold
0
– – – 6918
2023
Q2 		– Hold
0
– – – 6648
2023
Q1 		– Hold
0
– – – 6908
2022
Q4 		– Hold
0
– – – 6720
2022
Q3 		– Hold
0
– – – 6604
2022
Q2 		– Hold
0
– – – 6628
2022
Q1 		– Hold
0
– – – 6757
2021
Q4 		– Hold
0
– – – 6764
2021
Q3 		– Hold
0
– – – 6607
2021
Q2 		– Hold
0
– – – 6247
2021
Q1 		– Sell
-2
Closed -$439K – 5539
2020
Q4 		$341K Buy
2
+1
+100% +$155K ﹤0.01% 4577
2020
Q3 		$80K Hold
1
– – ﹤0.01% 4794
2020
Q2 		$73K Buy
+1
New +$122K ﹤0.01% 4683

Other funds holding GNPX

Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EGM
Engineers Gate Manager New York $7.71B AUM 24.88% 1-Year Est. Return
MFA
Mayflower Financial Advisors Boston, Massachusetts $1.16B AUM 24.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return

JP Morgan Chase's GNPX Position: Q2 2026 in Review

JP Morgan Chase held its Genprex (GNPX) position steady in Q2 2026 at 0 shares worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #7692.

JP Morgan Chase first reported a position in GNPX in Q2 2020 and has held it in 3 quarters since. The position peaked at $341K in Q4 2020. 17 funds tracked by Wall St. Rank hold GNPX as of Q2 2026.

  • JP Morgan Chase held 0 shares of Genprex worth $1 as of Q2 2026.
  • JP Morgan Chase left its Genprex share count unchanged in Q2 2026.
  • Genprex made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7692 holding.
  • JP Morgan Chase first reported a position in Genprex in Q2 2020 and has held it in 3 quarters since.
  • JP Morgan Chase's Genprex position peaked at $341K in Q4 2020.
  • 17 funds tracked by Wall St. Rank held Genprex as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.